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Analyses of hypertensive confounding factors were identified by looking 
retrospectively at patient demographics, medications, recent blood pressure and the 
medical history of hypertensive patients with diabetes. The data trends found in this 
database highlighted potential areas for improvement with regards to the care of patients 
with this co-morbidity in the outpatient setting. All prescription anti-hypertensives 
prescribed for the 102 patients followed the National Joint Committee (JNC-8) 
Hypertension Guideline Algorithm. Of 102 adult males (over the age of 18), 22 patients 
had a blood pressure that is out of control (over 140/90). Within this group of patients, 
33.3% of the patients are overweight with a body mass index between 25.0 and 29.9. 
Patients were obese 60.8% of the time with a BMI of 30.0 and above. Half of the patients 
(51 of 102) have an active diagnosis of obstructive sleep apnea. There is a need for 
continued aggressive treatment of hypertension in order to keep blood pressure below the 
recommended 140/90mmHg per the JNC-8 Hypertension Guidelines for hypertensive 
and diabetic patients. Several evidence-based practice recommendations were provided to 
address the clinically significant findings mentioned above.   
















Evaluation of Hypertensive Clinical Significance in a Primary Care Setting with Veterans 
with Diabetes 
 
Background & Significance 
 
According to the Centers for Disease Control, National Vital Statistical Report, 
there were 30,221 deaths from essential hypertension and hypertensive renal disease in 
the United States in 2014. Nearly 75 million American adults have high blood pressure, 
which is approximately one in every three adults. Of the 75 million adults with 
hypertension, only about 54% have their hypertension in control. Early treatment of 
hypertension is especially important in diabetic patients both to prevent cardiovascular 
disease and to minimize the progression of renal disease and diabetic retinopathy (Gaede, 
1999). There are many negative health outcomes associated with elevated blood pressure 
including the risk for heart disease and stroke.  
An estimated $48.6 billion dollars is spent yearly on hypertensive disease, which 
includes the cost of health care services, medications to treat high blood pressure, and 
missed days of work (Centers for Disease Control). Thus, aggressive treatment of 
hypertension is not only the best thing for the wellbeing of patients, but it also has an 
economic burden on our healthcare system and country.  
Patients that are overweight or obese are at an increased risk of having 
hypertensive disease. There is an overwhelming prevalence of both overweight and obese 
patients in the United States. More than two-thirds of adults in the U.S are overweight or 
obese according to the Centers for Disease Control. It is known that type-2 diabetes 
mellitus and hypertension are associated with obesity. Thus, it is important to evaluate 
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the blood pressure and confounding factors that are contributing to both hypertension and 
diabetic discourse. 
The Joint National Committee (JNC) published the “2014 Evidence Based 
Guideline for the Management of High Blood Pressure in Adults”, which includes the 
JNC – 8 Hypertension Guideline Algorithm for treatment of hypertension in various 
subgroups. The guideline includes recommended lifestyle changes and pharmacotherapy 
that is based on various co-morbid conditions. This guideline was used as a map for this 
evidence based project. The current practices of the clinic were evaluated using the 
guideline as an evidence based tool for best practice.  
Evidence Based Practice Model 
The beginning steps of the IOWA model were used to guide the planning of the 
project. The IOWA model is presented in a flow chat format with many feedback loops to 
ensure proper direction within a project. This helps to ensure that the user is meeting 
certain criteria prior to moving too far into the project in order to help guarantee success 
later on. The starting point of the IOWA model begins with a question concerning 
clinical practice, either a problem focused trigger or a knowledge-focused trigger. With 
regards to the evaluation of the hypertensive data set, the project trigger is a knowledge-
focused trigger. There is not a direct “problem” that is causing the need for change, but 
rather, the knowledge that best practice may not be currently adhered to, and we could do 
better.  
The IOWA model also has a question in the beginning of the model that asks whether 
or not the project is an organizational priority. If the topic or problem is not of 
importance to the institution, then the model recommends rethinking the project idea 
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entirely. This topic was proposed by the overseeing physician and was expressed as a 
priority. The IOWA model was fitting for planning this particular evidence based practice 
project and will continue to serve as a beneficial guide for the organization moving 
forward.  
Project Plan Process 
 A Nurse Practitioner, Doctor of Philosophy student, accessed an electronic health 
record at an outpatient Veterans Administration (VA) internal medicine clinic. From the 
health record, a de-identified clinical database was assessed with hypertensive patient 
demographics, medical history, family history and co-morbid diagnoses. The 
demographics included in the database consisted of the following: age, sex, race, religion, 
and military branch. Social behaviors such as tobacco use and alcohol use were also 
included. Psychiatric medical history was included only if it was one of the following 
conditions: major depressive disorder, generalized anxiety disorder, post traumatic stress 
disorder. The following medical conditions were included, obstructive sleep apnea 
(OSA), congestive heart failure (CHF), coronary artery disease (CAD), dyslipidemia, 
chronic kidney disease (CKD), diabetes mellitus (DM), and a history of a transient 
ischemic attack (TIA) or a cerebrovascular accident (CVA).  
 The database also included most recent lab values for hemoglobin A1C, HDL, 
and body mass index (BMI). Antihypertensive medications including dosing prescribed 
to the patient were included. There was a range from zero to four antihypertensive 
medications prescribed. Baseline and most recent blood pressure readings were 
incorporated and used to assess whether or not blood pressure was in control or not. 
Finally, the database had family history within specific diagnoses that are most related to 
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cardiac disease and cardiac risk factors. The following family history was included: 
hypertension (HTN), cerebrovascular accident (CVA), myocardial infarction (MI), 
coronary artery disease (CAD), and diabetes mellitus (DM). All of the patients in the 
database had an ICD-10 billing code of hypertension. By creating data trends and looking 
at the JNC-8 Guidelines, only certain factors were used in the analysis of confounding 
factors to hypertension and diabetes. 
There were 325 adult patients (over the age of 18) with a diagnosis of 
hypertension within the provided database during the dates of August 1st, 2014 through 
July 31st, 2016. Of the 325 patients, there were 108 patients with an active diagnosis 
(ICD-10 code) of diabetes mellitus type II. The JNC-8 Hypertension Guideline Algorithm 
begins by specifying that the tool is written for adults over the age of 18. It begins with 
the recommendation that lifestyle modifications are implemented, a set blood pressure 
goal is created and blood pressure lowering medications are started based on the 
algorithm. The lifestyle changes are comprised of the following: smoking cessation, 
blood glucose and lipid control, dietary changes and physical activity. Dietary changes 
including healthy eating in which the Dietary Approaches to Stop Hypertension (DASH) 
diet is recommended. Moderate alcohol consumption and a reduced sodium intake to no 
more than 2,400 mg/day. The physical activity recommendations include moderate to 
vigorous activity 3-4 days a week averaging 40 minutes per session.  
Next, the JNC-8 Hypertension Guideline Algorithm differentiates between the 
general population (no diabetes or CKD) and patients with diabetes or chronic kidney 
disease (CKD). For the purposes of this project, the patients with the co-morbidity of 
diabetes were selected. It is critical to prevent chronic kidney disease or renal failure in 
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this population. Patients with both hypertensive disease and diabetes are at a significant 
risk of poor health outcomes.  
Male patients were included in the analysis. There were a total of 102 adult male, 
veteran patients with an active diagnosis of both hypertension and diabetes type II. 
Within the diabetic/hypertensive co-morbid diagnosis on the algorithm, the blood 
pressure goal is goal less than 140/90. Of note, patients age 60 and above without 
diabetes or chronic kidney disease have a more liberal blood pressure goal of less than 
150/90. This does not apply for geriatric patients over 60 with diabetes due to the 
increased cardiovascular risk with this comorbidity. Thus, all patients at any age with 
both hypertension and diabetes have a blood pressure goal of 140/90 or below.  
According to the guideline, patients are then divided into either black or non-
black. This category will help to determine the pharmacotherapy recommendations for 
the patient. From this point, each of the patients within this co-morbid group, were 
divided into patients that were either black or non-black per the guideline. There were 83 
nonblack patients and nineteen black patients with hypertension and diabetes. The most 
recent blood pressure was then analyzed to see if the blood pressure is in control 
(<140/90) or out of control (>140/90). Of the 83 non-black patients, twenty-one of the 
patients had a blood pressure that is considered out of range and of the black patients, 
there was one patient with a blood pressure out of control. The pharmacotherapy that was 
prescribed to each of the patients with a blood pressure that is out of range was analyzed 




Evaluation & Results 
Outcomes  
This next section discusses the evidence based practice project outcomes. Blood pressure 
control, the antihypertensives prescribed to the patient, body mass index, obstructive 
sleep apnea, and other contributing factors are discussed herein.  
Blood Pressure Control. Out of 102 adult males with a diagnosis of diabetes 
mellitus type 2 and hypertension, twenty-two patients had a blood pressure that is out of 
control (over 140/90). All prescription antihypertensives followed the National Joint 
Committee (JNC) Hypertension Guideline Algorithm.  
Anti-Hypertensive’s Prescribed. All prescription antihypertensives followed the 
National Joint Committee (JNC) Hypertension Guideline Algorithm. The medications are 
specific to patients with both hypertension and diabetes. Also, the medication 
recommendations differ between black and non-black patients. Of the 102 adult males, 
twenty-two patients had a blood pressure of 140/90 or above. One of the twenty-two 
patients is a black male, and the other twenty-one patients are considered non-black.  
The one black patient with an elevated blood pressure is on two anti-hypertensive 
medications. The medications prescribed were hydroclorothiazide (HCTZ) 25 mg per day 
and verapamil 240mg daily. Both medications are according to the JNC guidelines. The 
twenty-one non-black patients with elevated blood pressure were on varying medication 
regimens but all pharmacologic therapy was prescribed according to recommendations. 
Two of the patients were on no medications. Eight of the patients were on single therapy. 
Four of the patients are on double therapy. Six of the patients are on triple therapy.  And, 
finally, one patient was on quadruple therapy.  
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Out of the eight patients on single therapy, six of the patients were prescribed 
lisinopril, which is an angiotensin-converting-enzyme inhibitor (ace-inhibitor). The 
dosing ranged from 5mg to 40mg per day. One patient was prescribed metoprolol 50mg 
per day, which is a beta-blocker. The last patient was prescribed a calcium channel 
blocker (CCB), amlodipine 10mg daily. The recommended therapy in diabetic 
hypertensive patients is an ace-inhibitor or an angiotensin II receptor blocker (ARB), 
calcium channel blocker (CCB) or diuretic.  
There were four of the twenty-one patients prescribed dual therapy. Patient one 
was on atenolol 50 mg per day and losartan 100mg per day. Patient two was on 
metoprolol 100mg per day and lisinopril 10mg per day. Patient three was on HCTZ 25mg 
daily and losartan 100mg daily. The forth patient was on HCTZ 25mg per day and 
lisinopril 40mg per day.  
Five of the twenty-one patients were prescribed triple therapy. Patient one and 
two were on the same three medications, although doses varied. The two patients were 
both on amlodipine (10mg daily), atenolol (25mg and 100mg daily), and lisinopril (40mg 
every day). The other two patients were prescribed different medication combinations. 
Patient three was prescribed amlodipine 4mg daily, atenolol 100mg daily and losartan 
100mg per day. Patient four was prescribed spironolactone 25 mg, furosemide 80mg and 
metoprolol 50mg per day. Finally, patient five was on HCTZ 25mg/triamterene 37.5mg, 
atenolol 50mg daily and lisinopril 40mg a day. 
Finally, two of the twenty-one patients were prescribed quadruple therapy. Patient 
one was prescribed an ace-inhibitor, beta-blocker, diuretic and centrally-acting agent. The 
specific medications that patient one was prescribed include the following: lisinopril 
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40mg per day, atenolol 100mg daily, HCTZ 25mg per day, and clonidine 0.1 mg daily.  
This combination of medications follows the JNC-8 Guidelines. Patient two was 
prescribed HCTZ 20mg/lisinopril 20mg, furosemide 20mg daily, and metoprolol 100mg 
per day. See table 1.  
Body Mass Index. Of the 102 patients, 33.3% of the patients are overweight with 
a body mass index between 25.0 and 29.9. And, 60.8% of these patients were obese with 
a BMI of 30.0 and above. Therefore, approximately 94% of these patients are suffering 
from being either overweight or obese. Only 5.9% of the patients were considered to have 
a healthy weight. See figure 1. With regards to the twenty-two patients with a blood 
pressure above 140/90, only two out of the twenty-two (9.1%) patients are at a healthy 
weight (BMI 18.5 to 24.9). Therefore, eight out of the twenty-two (36.4%) patients are 
overweight (BMI 25 to 29.9). Finally, twelve out of the twenty-two (54.5%) patients are 
obese (BMI 30 and above). Together, 91% of the patients with elevated blood pressure 
are either overweight or obese.   
Obstructive Sleep Apnea. Half  (50%) of the patients (51 of out 102) have an 
active diagnosis of obstructive sleep apnea (OSA). See figure 2. This data is based of an 
active ICD-10 code within the patient’s medical record. The group of patients with 
elevated blood pressure, over 140/90, 59% (13/22) had an active diagnosis of obstructive 
sleep apnea. Therefore, 41% (9/22) of the patients with an elevated blood pressure do not 
have an active diagnosis of obstructive sleep apnea. These patients are not currently being 
screened for OSA and therefore, there is an opportunity to screen this patient population. 
If these patients have OSA, but are not being treated for the disease, it may be 
contributing to their high blood pressure and even making it more difficult to decrease. A 
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prospective cohort study of 1889 participants was conducted by Marin, et al. (2013) and 
found that “compared with participants without OSA, the presence of OSA was 
associated with increased adjusted risk of incident hypertension; however, treatment with 
CPAP therapy was associated with a lower risk of hypertension.” In order to compare the 
prevalence of obstructive sleep apnea in patients with both hypertension and diabetes, an 
analysis of the number of patients with OSA with hypertension without diabetes was 
performed. There were 180 patients within the cohort with an active diagnosis of 
hypertension without diabetes. Of the 180 patients, 75 (41.7%) patients have an active 
diagnosis of OSA. Consequently, there was a lower incidence of OSA in patients with 
hypertension and no diabetes.  
Other Contributing Factors. After analyzing various other risk factors that 
could be contributing to the hypertensive and diabetic patient’s cardiovascular health, 
there were a significant number of patients with an active diagnosis of dyslipidemia. Out 
of the 102 patients, 85.2% (87) have an active diagnosis of dyslipidemia. Of those 
patients, seventeen of them have blood pressure that is out of range (17/22 patients) or 
77.3% of the out of control patients also have dyslipidemia, contributing to their overall 
cardiovascular risk. 16.7% (17/102) have an active diagnosis of coronary artery disease 
(CAD), and two of the seventeen patients have blood pressure out of range. With regards 
to congestive heart failure (CHF), 4.9% (5/102) of the patients have an active diagnosis 
of CHF, and all (100%) are in hypertensive control.  
Evidence Based Practice Suggestions 
It is imperative to aggressively treat hypertensive patients to obtain hypertensive 
control, especially in the setting of type-2 diabetes mellitus. According to the JNC-8 
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Guidelines, patients with an elevated blood pressure, initial presentation and subsequent 
readings, lifestyle modifications should be reinforced to the patient. “For all persons with 
hypertension, the potential benefits of a healthy diet, weight control, and regular exercise 
cannot be overemphasized” (James, et. al, 2014). There are an overwhelming number of 
patients that are either overweight of obese with the co-morbidity of hypertension and 
type-2 diabetes mellitus in this group of veteran patients. According to the JNC-8 
Guidelines, weight reduction is a priority for hypertensive patients. Specifically, the 
guideline suggests the DASH diet for hypertensive/diabetic patients. The DASH diet is 
endorsed by The National Heart, Lung and Blood Institute, the American heart 
Association (AHA) and the Mayo Clinic. The DASH diet has been proven to decrease 
systolic and diastolic blood pressure. This is largely due to the diets sodium restriction. 
Therefore, all of the patients with these ICD-10 codes will be referred for nutritional 
counseling to obtain education on the DASH diet.  The providers at this outpatient clinic 
were educated on the DASH diet and low-sodium diet (may be done through dietician). 
Weight management/ reduction in body mass index will be discussed with the patients in 
this clinic, especially for patients with an elevated blood pressure. Brown et. al (1989) 
completed a meta-analysis of 89 studies that assessed educational interventions and 
outcomes specific to weight loss in diabetes care. The studies included demonstrated 
support for diabetes education in primary care, specifically; nutritional therapy 
counseling had the largest statistically significant impact on both weight loss and 
metabolic control. While, this meta-analysis focused on the diabetic population, the 
patients included in this analysis had both diabetes and hypertension. Control of both 
diseases can be assisted by weight reduction.  
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There is evidence to support group weight loss programs. While, these programs 
may be costly to run, the benefits may outweigh the risks with regards to long-term 
complications. Rock et. al (2014) performed a randomized controlled trial with 227 
overweight of obese with type-2 diabetes. The participants in the weight loss program, 
which included in person diet and exercise counseling, lost 7.8% of their initial weight as 
compared to 2.1% in the control group. The study found that a structured weight loss 
program resulted in greater weight loss and improved glycemic control in type-2 
diabetes, improving cardiovascular risk factors.  
There is research that demonstrates the increased risk of high blood pressure in 
patients with obstructive sleep apnea. In a prospective cohort study with 5,382 patients 
referred to sleep study, 922 of the patients initiated continuous positive airway pressure 
(CPAP) therapy. It was found that the presence of OSA was associated with an increased 
risk of incident hypertension (Marin, et. al, 2012). Also, there is evidence to support that 
it is more difficult to lower blood pressure if patients are suffering from OSA. In a 
randomized placebo controlled cross over study, the effects of four weeks of CPAP on 68 
patients with hypertension were studied. The patients were not receiving hypotensive 
medications.  Blood pressure was reduced by greater amounts in patients with 
intermittent nocturnal hypoxemia with the use of CPAP and systolic blood pressure was 
decreased by 4.0mm Hg and diastolic blood pressure by 5.0mm Hg. For this reason, this 
clinic will begin screening all patients with co-morbid diagnosis for obstructive sleep 
apnea. Any patients with hypertension and possible sleep apnea will be referred for sleep 
study and CPAP, if indicated.  
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Sleep apnea is more prevalent in patients with type-2 diabetes than patients 
without diabetes. Einhorn et al. (2007) completed a study with 279 adults with type- 2 
diabetes. They found that there was a high prevalence of OSA in the diabetic patient 
population. They found that sleep apnea was associated with males, ages 62 and older, 
with a body mass index greater than or equal to 30kg/m2, snoring and reports of stopping 
breathing during sleep. Storgarrd et al. (2014) also found that approximately one third of 
patients with type-2 diabetes also had a co-morbidity of obstructive sleep apnea with a 
cross-sectional study including 200 participates. Therefore, it is even more important that 
patients with both hypertension and diabetes are screened for obstructive sleep apnea on a 
regular basis. Within the cohort of veterans in this study, patients with a diagnosis of 
hypertension without diabetes or chronic kidney disease, had a diagnosis of obstructive 
sleep apnea 41.7% of the time, compared to a prevalence of 50% of the patients with 
hypertensive patients with diabetes. This cohort of patients is reflective of the studies and 
research previously mentioned above.   
 
Implications for clinical practice 
Several future Doctor of Nursing Practice (DNP) students will implement the 
clinically significant outcomes and recommendations identified from this research. One 
student will begin screening patients with this co-morbidity for obstructive sleep apnea 
using either the STOP-Bang Screening tool or the Epworth Sleepiness Scale (ESS).  This 
will help to identify patients that are suffering from OSA but have not been diagnosed 
and treated. Also, due to the large percentage of both overweight and obese patients in 
this data set, a student will implement the recommended interventions to reduce body 
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mass index (BMI). The identified areas of concern, increased BMI and high prevalence 
of OSA will be addressed by these students and hopefully will then decrease blood 
pressure in these patients. Clinically, there is still a need for further intervention in this 
population, as there is work to do in order to meet blood pressure goal standards. With 
regards to future research, it would be interesting to look at the relationship between 
patients with both hypertension and diabetes and other psychosocial contributing factors 
such as anxiety, depression and post-traumatic stress disorder (PTSD). Also, it would be 
helpful to have a better understanding of how often patients actually use their CPAP 
machines and any interventions that may increase compliance.  
There are many areas within this patient population in which further education 
could be beneficial. This could be evaluated with a pre and posttest to gain a better idea 
of how much these patients understand the diseases and the consequences of poor blood 
pressure control over time. There is an opportunity formation of new statewide or 
national policy that encourages lifestyle changes among these patients through the use of 
incentives. Due to the complications associated with uncontrolled hypertension, 
especially in the setting of diabetes, there can be financial savings long term if blood 
pressure is controlled.  
 
Conclusions 
There is a need for continued aggressive treatment of hypertension to maintain 
blood pressure at or below the recommended 140/90mmHg per the JNC-8 Hypertension 
Guidelines for hypertensive and diabetic patients. All patients with a co-morbidity of 
hypertension and diabetes should be referred for nutritional counseling. Also, the Dietary 
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Approach to Stop Hypertension (DASH) diet should be recommended to these patients. 
Weight management should be discussed with these patients. Finally, patients with 
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